Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K W Peng

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
The Journal of Gene Medicine|April 25, 2001
Concentration of viral vectors by co-precipitation with calcium phosphateL Pham, H Ye, F L Cosset, et al.
Gene Therapy|April 22, 2003
Targeting the cytotoxicity of fusogenic membrane glycoproteins in gliomas through protease-substrate interactionK J Johnson, K-W Peng, C Allen, et al.
Cancer Gene Therapy|April 10, 2010
Oncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapyH Li, K-W Peng, D Dingli, et al.
Human Gene Therapy|April 10, 1997
A gene delivery system activatable by disease-associated matrix metalloproteinasesK W Peng, F J Morling, F L Cosset, et al.
Gene Therapy|October 20, 2006
Evaluation of T cells as carriers for systemic measles virotherapy in the presence of antiviral antibodiesH T Ong, K Hasegawa, A B Dietz, et al.
Cancer Gene Therapy|September 14, 2013
Overcoming cancer cell resistance to VSV oncolysis with JAK1/2 inhibitorsD Escobar-Zarate, Y-P Liu, L Suksanpaisan, et al.
Gene Therapy|June 25, 2004
Targeting virus entry and membrane fusion through specific peptide/MHC complexes using a high-affinity T-cell receptorK-W Peng, P D Holler, B A Orr, et al.
Leukemia|March 20, 2012
Curative one-shot systemic virotherapy in murine myelomaS Naik, R Nace, M J Federspiel, et al.
Cancer Gene Therapy|November 26, 2011
Polyinosinic acid decreases sequestration and improves systemic therapy of measles virusY-P Liu, C Tong, A Dispenzieri, et al.
Blood|September 25, 2001
Systemic therapy of myeloma xenografts by an attenuated measles virusK W Peng, G J Ahmann, L Pham, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
The Journal of Gene Medicine|April 25, 2001
Concentration of viral vectors by co-precipitation with calcium phosphateL Pham, H Ye, F L Cosset, et al.
Gene Therapy|April 22, 2003
Targeting the cytotoxicity of fusogenic membrane glycoproteins in gliomas through protease-substrate interactionK J Johnson, K-W Peng, C Allen, et al.
Cancer Gene Therapy|April 10, 2010
Oncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapyH Li, K-W Peng, D Dingli, et al.
Human Gene Therapy|April 10, 1997
A gene delivery system activatable by disease-associated matrix metalloproteinasesK W Peng, F J Morling, F L Cosset, et al.
Gene Therapy|October 20, 2006
Evaluation of T cells as carriers for systemic measles virotherapy in the presence of antiviral antibodiesH T Ong, K Hasegawa, A B Dietz, et al.
Cancer Gene Therapy|September 14, 2013
Overcoming cancer cell resistance to VSV oncolysis with JAK1/2 inhibitorsD Escobar-Zarate, Y-P Liu, L Suksanpaisan, et al.
Gene Therapy|June 25, 2004
Targeting virus entry and membrane fusion through specific peptide/MHC complexes using a high-affinity T-cell receptorK-W Peng, P D Holler, B A Orr, et al.
Leukemia|March 20, 2012
Curative one-shot systemic virotherapy in murine myelomaS Naik, R Nace, M J Federspiel, et al.
Cancer Gene Therapy|November 26, 2011
Polyinosinic acid decreases sequestration and improves systemic therapy of measles virusY-P Liu, C Tong, A Dispenzieri, et al.
Blood|September 25, 2001
Systemic therapy of myeloma xenografts by an attenuated measles virusK W Peng, G J Ahmann, L Pham, et al.
Pageof 4